Italia markets closed

ResMed Inc. (RMD.AX)

ASX - ASX Prezzo differito. Valuta in AUD.
Aggiungi a watchlist
27,92+0,29 (+1,05%)
Alla chiusura: 04:10PM AEST

ResMed Inc.

9001 Spectrum Center Boulevard
San Diego, CA 92123
United States
858-836-5000
https://www.resmed.com

Settore/iHealthcare
SettoreMedical Instruments & Supplies
Impiegati a tempo pieno

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Michael J. Farrell BE, MBA, SMCEO & Chairman4,47M17,43M1972
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScDFounder, Chair Emeritus & Director669,65kN/D1942
Mr. Brett A. SandercockChief Financial Officer1,42M2,78M1967
Mr. Robert A. DouglasSpecial Advisor2,98M13,97M1960
Mr. Kaushik GhoshalChief Commercial Officer - SaaS1,73MN/D1969
Ms. Amy WakehamChief Investor Relations OfficerN/DN/DN/D
Mr. Michael J. RiderChief Legal OfficerN/DN/D1958
Mr. Jim EllisChief Compliance OfficerN/DN/DN/D
Ms. Yvonne-Katrin PucknatChief Marketing OfficerN/DN/DN/D
Ms. Vered KeisarChief People OfficerN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in AUD.

Descrizione

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.

Governance aziendale

L'ISS Governance QualityScore di ResMed Inc. al 1 aprile 2024 è 4. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 8; diritti degli azionisti: 3; retribuzione: 7.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.